| SciPort RLP

2015 - 2018

Lampalizumab GX29185: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

Dr. Katharina,
PD Dr. Katrin

2015 - 2018

Additive application of the natural histone acetylase (HDAC) inhibitors sulforaphane – A strategy for the avoidance of therapy resistance against everolimus in renal cell carcinoma?

PD Dr. Eva

2015 - 2018

SETPOINT2: Stroke-Related Early Tracheostomy versus Prolonged Orotracheal Intubation in Neurocritical care Trial 2

Dr. Thomas

2015 - 2017

FishUP - Sensimed Triggerfish Utility Program

PD Dr. Katrin

2015 - 2018

Axitinib versus sorafenib in sunitinib-resistant renal cell carcinoma – molecular biological analyses on a resistant endothelial cell model

PD Dr. Eva

2015 - 2016

Ganfort (201450): A phase IV study on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops (bimatoprost 0.03%/timolol 0.5%) to Taptiqom® eye drops (tafluprost 0.0015%/timolol 0.5%).

PD Dr. Katrin

2015 - 2020

The significance of amygdalin in the therapy of renal cell carcinoma

PD Dr. Eva

2015 - 2016

IRISS: AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN® 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR

Prof. Dr. Norbert

2015 - 2017

Lebensqualität von Patienten mit Leberzirrhose und Hepatischer Enzephalopathie unter einer routineärztlichen Behandlung mit L-Ornithin-L-Aspartat über 12 Wochen

Dr. Marc

2015 - 2017

Actovegin and Traumeel Affects Biological Function of Primary Human Skeletal Muscle Cells – an in vitro study

Dr. Stefan,
Dr. Ulrike,
Prof. Dr. Philipp

Starten Sie Ihre Suche...

Johannes Gutenberg-Universität Mainz